<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01049555</url>
  </required_header>
  <id_info>
    <org_study_id>09-PP-06</org_study_id>
    <nct_id>NCT01049555</nct_id>
  </id_info>
  <brief_title>Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research</brief_title>
  <acronym>09-PP-06</acronym>
  <official_title>Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuropsychiatric symptoms form part of the clinical picture of Alzheimer's disease (AD) and
      other dementias. Irrespective of the severity of the disease, the most frequently encountered
      symptom is apathy. Apathy is increasingly diagnosed in patients with neurological and
      psychiatric conditions. Apathy is a disorder of motivation, defined as &quot;the direction,
      intensity and persistence of goal-directed behaviour&quot;. Most of the current descriptions
      acknowledge this point and consider apathy in terms of a lack of goal-directed behaviour,
      cognition or emotion. The classical neuropsychiatric symptom assessments are subjective
      structured interview-based, using input from the caregiver and/or the patient. New
      technologies are likely to provide us with a more objective measure. An example is ambulatory
      actigraphy, consisting of a piezoelectric accelerometer designed to record arm movement in
      three dimensions.

      The aim of the present study is to assess using actigraphy and video recording signal, AD
      patients with (n = 15) and without (n = 15) apathy and control subjects (n = 5) during an
      activity of daily living scenario .
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>assessment of motricity</measure>
    <time_frame>one time point - at the only visit of protocol</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>video recording</measure>
    <time_frame>one time point - at the only visit of the protocol</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>Alzheimer and apathy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Alzheimer's disease patients with apathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alzheimer without disease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Alzheimer's disease patients without apathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Case control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subject without apathy neither Alzheimer's disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Actigraphy and video recording signal</intervention_name>
    <description>Actigraphy and video recording signal during 1 hour</description>
    <arm_group_label>Alzheimer and apathy</arm_group_label>
    <arm_group_label>alzheimer without disease</arm_group_label>
    <arm_group_label>Case control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female, &gt; 65 years ;

          -  Alzheimer's disease according to the NINCDS-ADRDA criteria (McKhann,Drachman et al.
             1984) ;

          -  Mini Mental Test Examination (MMSE) &gt; 20 ;

          -  no motor anomaly according to UPDRS III (tremblements, rigidit√© musculaire) ;

          -  no depression criteria according to DSM IV-R criteria ;

          -  patient with a cholinergic treatment at dose stable since 3 months ;

          -  patient with social insurance ;

          -  signature of informed consent.

        Exclusion Criteria:

          -  neuropsychologics assessment impossible due to sensorial and disrupt ;

          -  prescription of psychotrop treatment (hypnotic, anxiolytic, antidepressant,
             antipsychotic) in the week previous actigraphy recording.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe ROBERT, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nice University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nice University Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2010</study_first_submitted>
  <study_first_submitted_qc>January 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2010</study_first_posted>
  <last_update_submitted>September 29, 2015</last_update_submitted>
  <last_update_submitted_qc>September 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>alzheimer</keyword>
  <keyword>apathy</keyword>
  <keyword>actigraphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

